fusidic acid has been researched along with tauro-24,25-dihydrofusidate in 22 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (tauro-24,25-dihydrofusidate) | Trials (tauro-24,25-dihydrofusidate) | Recent Studies (post-2010) (tauro-24,25-dihydrofusidate) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 22 | 1 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 17 (77.27) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitra, AK; Shao, Z | 1 |
| Illum, L; Richardson, JL; Thomas, NW | 1 |
| Bantle, S; Beglinger, C; Drewe, J; Kissel, T; Rummelt, A | 1 |
| Lee, WA; Narog, BA; Patapoff, TW; Wang, YJ | 1 |
| Breimer, DD; de Boer, AG; Heijligers-Feijen, CD; van Hoogdalem, EJ; Verhoef, JC | 1 |
| Borden, L; Ennis, RD; Lee, WA | 1 |
| Baldwin, PA; Grimm, CJ; Klingbeil, CK; Longenecker, JP | 1 |
| Hermens, WA; Hooymans, PM; Merkus, FW; Verhoef, JC | 1 |
| Deurloo, MJ; Hermens, WA; Merkus, FW; Romeyn, SG; Verhoef, JC | 1 |
| Breimer, DD; de Boer, AG; Heijligers-Feijen, CD; Mathôt, RA; van Bree, JB; van Hoogdalem, EJ; Verhoef, JC; Wackwitz, AT | 1 |
| Merkle, HP; Raehs, SC; Sandow, J; Wirth, K | 1 |
| Carey, MC; Dubovi, EJ; Flier, JS; Longenecker, JP; Moses, AC; Silver, RD | 1 |
| Blom-Roosemalen, MC; Breimer, DD; de Boer, AG; Hurni, MA; Nagelkerke, JF; Noach, AB | 1 |
| Hosoya, K; Kubo, H; Morimoto, Y; Natsume, H; Sugibayashi, K | 2 |
| Bengtsson, P; Ennis, RD; Lee, WA; Longenecker, JP | 1 |
| Albertsson-Wikland, K; Diczfalusy, M; Flyg, C; Hedin, L; Olsson, B; Petersson, AS; Rosberg, S | 1 |
| Chung, YB; Han, K; Lee, MJ; Moon, DC; Park, JS; Robinson, JR | 1 |
| Adriaens, E; Mertens, J; Remon, JP; Voorspoels, J | 1 |
| Cullander, C; Marttin, E; Merkus, FW; Nagelkerke, JF; Romeijn, SG; Verhoef, JC | 1 |
| Akutsu, T; Hosoya, K; Kubo, H; Morimoto, Y; Natsume, H; Sugibayashi, K | 1 |
| Agu, RU; Augustijns, P; Jorissen, M; Kinget, R; Verbeke, N; Willems, T | 1 |
1 trial(s) available for fusidic acid and tauro-24,25-dihydrofusidate
| Article | Year |
|---|---|
Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects.
Topics: Administration, Intranasal; Adult; Biological Availability; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Fusidic Acid; Humans; Lasers; Male; Octreotide; Reference Values; Scattering, Radiation | 1992 |
21 other study(ies) available for fusidic acid and tauro-24,25-dihydrofusidate
| Article | Year |
|---|---|
Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: correlation with facilitated drug transport.
Topics: 5'-Nucleotidase; Acyclovir; Animals; Bile Acids and Salts; Fatty Acids; Fusidic Acid; Glycocholic Acid; L-Lactate Dehydrogenase; Linoleic Acid; Linoleic Acids; Male; Membrane Proteins; Nasal Mucosa; Rats; Rats, Sprague-Dawley; Taurocholic Acid | 1992 |
Vaginal absorption of insulin in the rat: effect of penetration enhancers on insulin uptake and mucosal histology.
Topics: Absorption; Adjuvants, Pharmaceutic; Administration, Intravaginal; Animals; Blood Glucose; Buffers; Epithelial Cells; Epithelium; Female; Fusidic Acid; Insulin; Lysophospholipids; Rats; Rats, Wistar; Vagina | 1992 |
Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.
Topics: Absorption; Adjuvants, Pharmaceutic; Administration, Intranasal; Aerosols; Animals; Biological Availability; Female; Fusidic Acid; Insulin; Nasal Mucosa; Permeability; Powders; Proteins; Solutions | 1991 |
Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in rats.
Topics: Administration, Rectal; Animals; Biological Availability; Blood Glucose; Edetic Acid; Fusidic Acid; Infusions, Intravenous; Insulin; Intestinal Absorption; Male; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1990 |
The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: a scanning electron microscopy study.
Topics: Animals; Bile Acids and Salts; Buffers; Cell Membrane Permeability; Dose-Response Relationship, Drug; Fusidic Acid; Male; Microscopy, Electron, Scanning; Nasal Mucosa; Phosphates; Polyethylene Glycols; Rats; Rats, Inbred Strains; Surface-Active Agents; Time Factors | 1990 |
The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.
Topics: Absorption; Animals; Biological Availability; Dose-Response Relationship, Drug; Fusidic Acid; Growth Hormone; Humans; Male; Nasal Mucosa; Rabbits; Rats; Rats, Inbred Strains; Sheep; Structure-Activity Relationship; Surface-Active Agents | 1990 |
Effects of absorption enhancers on human nasal tissue ciliary movement in vitro.
Topics: Absorption; Adenoids; Adjuvants, Pharmaceutic; Chemical Phenomena; Chemistry, Physical; Fusidic Acid; Humans; In Vitro Techniques; Insulin; Micelles; Mucociliary Clearance; Nasal Mucosa | 1990 |
Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats.
Topics: Administration, Intranasal; Animals; Biological Availability; Blood Glucose; Excipients; Fusidic Acid; Injections, Intravenous; Insulin; Male; Rabbits; Rats; Rats, Inbred Strains | 1989 |
Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
Topics: Animals; Arginine Vasopressin; Biological Availability; Cefoxitin; Fusidic Acid; Intestinal Absorption; Male; Rats; Rats, Inbred Strains; Rectum; Stimulation, Chemical | 1989 |
The adjuvant effect of bacitracin on nasal absorption of gonadorelin and buserelin in rats.
Topics: Absorption; Adjuvants, Pharmaceutic; Animals; Bacitracin; Buserelin; Dose-Response Relationship, Drug; Female; Fusidic Acid; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Nasal Mucosa; Ovulation; Rats; Rats, Inbred Strains; Rosaniline Dyes | 1988 |
Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep.
Topics: Absorption; Animals; Biological Availability; Female; Fusidic Acid; Hemolysis; Injections, Intravenous; Insulin; Nasal Mucosa; Rabbits; Sheep | 1987 |
Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
Topics: Adjuvants, Pharmaceutic; Biological Transport; Cell Membrane; Cell Membrane Permeability; Colonic Neoplasms; Dextrans; Electrophysiology; Epithelium; Fluorescein; Fluorescein-5-isothiocyanate; Fluoresceins; Fusidic Acid; Humans; Intestinal Absorption; Lasers; Lipid Metabolism; Microscopy; Sodium Salicylate; Trypan Blue; Tumor Cells, Cultured | 1993 |
Evaluation of enhancers to increase nasal absorption using Ussing chamber technique.
Topics: Absorption; Adjuvants, Pharmaceutic; Animals; Deoxycholic Acid; Dextrans; Fluorescein-5-isothiocyanate; Fusidic Acid; Lysophosphatidylcholines; Male; Nasal Mucosa; Phospholipids; Polidocanol; Polyethylene Glycols; Proteins; Rabbits; Sodium Dodecyl Sulfate | 1994 |
The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer.
Topics: Adjuvants, Pharmaceutic; Administration, Intranasal; Adult; Biological Availability; Calcitonin; Female; Fusidic Acid; Humans; Male; Radioimmunoassay | 1994 |
Intranasal administration of human growth hormone (hGH) in combination with a membrane permeation enhancer in patients with GH deficiency: a pharmacokinetic study.
Topics: Administration, Intranasal; Adolescent; Adult; Dose-Response Relationship, Drug; Drug Combinations; Female; Fusidic Acid; Growth Hormone; Humans; Injections, Subcutaneous; Male; Nasal Mucosa; Radioimmunoassay | 1993 |
Identification of enzymatic degradation products of luteinizing hormone releasing hormone (LHRH)/[D-Ala6] LHRH in rabbit mucosal homogenates.
Topics: Amino Acid Sequence; Animals; Edetic Acid; Female; Fusidic Acid; Gonadotropin-Releasing Hormone; Hydrolysis; In Vitro Techniques; Molecular Sequence Data; Mucous Membrane; Rabbits | 1995 |
Effect of absorption enhancers on ciliated epithelium: a novel in vivo toxicity screening method using rotifers.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Cilia; Cyclodextrins; Deoxycholic Acid; Epithelium; Fusidic Acid; Microscopy, Electron, Scanning; Phosphatidylcholines; Rotifera | 1997 |
Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Topics: Absorption; Adjuvants, Pharmaceutic; Administration, Intranasal; Animals; Biological Transport, Active; Dextrans; Epithelium; Fixatives; Fluorescein-5-isothiocyanate; Fusidic Acid; Male; Microscopy, Confocal; Molecular Weight; Nasal Mucosa; Rats; Rats, Wistar; Stimulation, Chemical | 1997 |
Effect of sodium taurodihydrofusidate on nasal drug delivery: differences in its concentration and penetrant molecular weight.
Topics: Adjuvants, Pharmaceutic; Administration, Intranasal; Animals; Anti-Asthmatic Agents; Cromolyn Sodium; Dextrans; Fluorescein-5-isothiocyanate; Fusidic Acid; In Vitro Techniques; Male; Molecular Weight; Nasal Mucosa; Rabbits | 1994 |
Evaluation of bile acids and fusidate derivative as nasal absorption enhancers using an electrophysiological technique.
Topics: Absorption; Administration, Inhalation; Animals; Bile Acids and Salts; Biological Transport; Dextrans; Dose-Response Relationship, Drug; Electric Impedance; Electrophysiology; Evaluation Studies as Topic; Fusidic Acid; In Vitro Techniques; Male; Membrane Potentials; Nasal Mucosa; Rabbits; Time Factors | 1999 |
In-vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies.
Topics: Administration, Intranasal; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Cilia; Collagen; Drug Delivery Systems; Fluorescein; Fusidic Acid; Humans; L-Lactate Dehydrogenase; Malate Dehydrogenase; Microscopy, Electron, Scanning; Nasal Mucosa | 2001 |